Page last updated: 2024-12-11

3-methylquinoxaline-2-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-methylquinoxaline-2-carboxylic acid: cytotoxic and genotoxic [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6484678
SCHEMBL ID2056931
MeSH IDM0585094

Synonyms (26)

Synonym
BB 0252879
3-methyl-quinoxaline-2-carboxylic acid
AKOS000558927
3-methylquinoxaline-2-carboxylic acid
74003-63-7
FT-0672133
AG-0701
STL476641
SCHEMBL2056931
3-methyl-2-quinoxalinecarboxylic acid
DTXSID10424475
2-quinoxalinecarboxylic acid, 3-methyl-
mfcd03840415
J-512929
3-methyl-2-quinoxalinecarboxylic acid, vetranal(tm), analytical standard
BCP25035
3-methyl-quinoxaline-2-carboxylic acid 100 microg/ml in acetonitrile
mqca
CS-W016815
C76365
A917111
HY-W016099
3-methylquinoxaline-2-carboxylicacid
EN300-226768
PD088829
Z1198163353

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The results indicate that 1,4-bisdesoxyquinocetone and MQCA are toxic to L-02 and Chang liver cells, and provide important new information towards understanding the olaquindox and quinocetone toxic mechanisms."( Cytotoxicity and genotoxicity of 1,4-bisdesoxyquinocetone, 3-methylquinoxaline-2-carboxylic acid (MQCA) in human hepatocytes.
Ban, M; Fei, C; Wang, M; Wang, X; Xue, F; Zhang, K; Zhao, Z; Zheng, H, 2012
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's10 (83.33)24.3611
2020's2 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.94 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]